AJMC Staff

The FDA is relaxing some time-based deferrals for donating blood; new guidance aims to streamline the COVID-19 vaccination process; Congress has been called on to solidify cannabidiol (CBD) regulations.

Coverage of our peer-reviewed research and news reporting in the health care and mainstream press.

Affordable Care Act health care sign-ups are breaking records; updated COVID-19 boosters are proving successful against new variants; GenBioPro, which manufactures mifepristone, has filed suit regarding the constitutionality of a state abortion drug ban.

After 3 years of continuous enrollment due to the pandemic, those on Medicaid will need to sign up again for coverage in April; fears about heavy metal levels in baby food prompt FDA to decrease lead exposure; long COVID is keeping large numbers of people out of work or needing medical care after returning.

Eli Lilly will tack on $450 million more to increase capacity in a diabetes drug plant in light of shortages; patients emailing and messaging medical providers online might be charged; 57% of adults in a recent survey think that the federal government should secure health care coverage for all Americans.

States in which recreational cannabis is legal see declining codeine prescriptions; the FDA plans to simplify the use of COVID-19 vaccines; state-wide abortion debates ramp up as Congress deadlocks

Despite a recent influx of new treatments, it is crucial to remind patients there is no cure for atopic dermatitis and follow-up care is important, explained Jerry Bagel, MD, director of the Eczema Treatment Center of New Jersey.

As the country hits the debt limit spending on Medicare and Medicaid may be at risk; the Agriculture Department targets fraudulent claims in products labeled as organic; first cases of drug-resistant gonorrhea strain found.

According to Eli Lilly's statement, the investigational drug worked quickly, so too few patients in the phase 2 study took it for a full year.

Coverage of our peer-reviewed research and news reporting in the health care and mainstream press.

Johnson & Johnson (J&J) ends late-stage HIV vaccine trial; mothers in states with abortion bans are almost 3 times more likely to die before, during, and after birth; Sanofi hopes to release a drug for hemophilia A in 2023.

CMS released accountable care organization (ACO) 2023 data; Chinese Lunar New Year travel threatens a COVID-19 toll in China; nursing homes to be audited for inappropriate antipsychotic drug usage.

The reality of a sickle cell disease cure brings fear, optimism, and questions to patients’ lives; veterans who are in suicidal crisis can receive free emergency care at any Department of Veterans Affairs or private facility; Pfizer to increase access to progressive treatments through sale of drugs at non-profit prices to poor countries.

Medical residents join unions for better pay and working conditions; the World Health Organization (WHO) appeals to China on COVID-19 information; health workers protest in Madrid, Spain.

Endometriosis is a very common disease across ethnic groups and the economic burden can be substantial for women, said Ayman Al-Hendy, MD, professor of obstetrics and gynecology at the University of Chicago Medicine.

Greater availability of naloxone spray, including over the counter, may reduce opioid overdoses; vaccination rates drop once again for US children; some experts question the necessity of the updated COVID-19 booster shot.

Coverage of our peer-reviewed research and news reporting in the health care and mainstream press.

Nurses in New York City reach agreement and end strike; hospitals benefiting from volunteer staff may be breaking labor laws; most lingering COVID symptoms will heal on its own, study finds.

Expanded health coverage sees an increase in enrollments; Antiabortion activists protest against CVS and Walgreens; $26,500 Alzheimer’s drug limits affordability

Ublituximab-xiiy, developed by TG Therapeutics, will be sold under the name Briumvi.

President Joe Biden expected to renew COVID-19 public health emergency (PHE) one more time; Bristol Myers Squibb and Pfizer are denied by the Supreme Court; funding for the 988 mental health helpline expands inclusivity efforts.

Pediatricians push for early action against childhood obesity, including prescription weight-loss medications and bariatric surgery; 7000 nurses go on strike in New York City; a new SARS-CoV-2 variant is more contagious but not necessarily more dangerous.

Compared with patients using other antipsychotics, patients with Parkinson disease using pimavanserin had lower death rates.

State courts in South Carolina and Idaho ruled in opposite ways on abortion bans; virtual COVID-19 diagnostic and treatment launches in community; generic methylphenidate medication shortages negatively impact ADHD treatment.

Coverage of our peer-reviewed research and news reporting in the health care and mainstream press.

HHS updated guidance for states using Medicaid managed care to manage nonmedical needs; anxieties surrounding new variants rise amidst underreported COVID-19 cases in China, which defended its counts; public health campaigns try new strategies to increase trust and promote immunizations.

Dual-regimen abortion pills authorized for pharmacy sale by FDA; health professionals turn a critical eye to US concerns about COVID-19 in China while domestic cases rise here as vaccination rates drop; drug manufacturers are collectively raising prices early this month on medications from autoimmune treatments to shingles vaccines to cancer treatments.

The Chinese government warns of backlash for countries requiring COVID-19 testing of travelers from China; monoclonal antibody drugs show some promise against infectious diseases, but costs need to be lower; the role of FDA and Biogen in approving Alzheimer drug Aduhelm is detailed in a scathing Congressional committee report.

The top 5 pieces of content published on AJMC.com relating to reimbursement issues included 2 on the significance of a California law giving Medicare beneficiaries access to expert oncology care; other articles looked at the work involved in value-based care models and CMS news.

Throughout 2022, expert interviews on clinical topics covered cytogenetics in multiple myeloma, access to better treatments in diffuse large B-cell lymphoma, and challenges with devices in chronic obstructive pulmonary disease.